| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Sphingosine 1-phosphate receptor 1 |
|---|
| Ligand | BDBM37273 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | Dose Response Assays for S1P1 Agonists and Agonism Potentiators - Agonist Assay 60K MLSMR |
|---|
| EC50 | 19980±n/a nM |
|---|
| Citation |  PubChem, PC Dose Response Assays for S1P1 Agonists and Agonism Potentiators - Agonist Assay 60K MLSMR PubChem Bioassay(2007)[AID] |
|---|
| More Info.: | Get all data from this article, Solution Info, Assay Method |
|---|
| |
| Sphingosine 1-phosphate receptor 1 |
|---|
| Name: | Sphingosine 1-phosphate receptor 1 |
|---|
| Synonyms: | CHEDG1 | EDG1 | Endothelial differentiation G-protein coupled receptor 1 | S1P receptor | S1P1 | S1PR1 | S1PR1_HUMAN | Sphingosine 1-phosphate receptor 1 (S1PR1) | Sphingosine 1-phosphate receptor Edg-1 |
|---|
| Type: | Enzyme |
|---|
| Mol. Mass.: | 42836.02 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P21453 |
|---|
| Residue: | 382 |
|---|
| Sequence: | MGPTSVPLVKAHRSSVSDYVNYDIIVRHYNYTGKLNISADKENSIKLTSVVFILICCFII
LENIFVLLTIWKTKKFHRPMYYFIGNLALSDLLAGVAYTANLLLSGATTYKLTPAQWFLR
EGSMFVALSASVFSLLAIAIERYITMLKMKLHNGSNNFRLFLLISACWVISLILGGLPIM
GWNCISALSSCSTVLPLYHKHYILFCTTVFTLLLLSIVILYCRIYSLVRTRSRRLTFRKN
ISKASRSSEKSLALLKTVIIVLSVFIACWAPLFILLLLDVGCKVKTCDILFRAEYFLVLA
VLNSGTNPIIYTLTNKEMRRAFIRIMSCCKCPSGDSAGKFKRPIIAGMEFSRSKSDNSSH
PQKDEGDNPETIMSSGNVNSSS
|
|
|
|---|
| BDBM37273 |
|---|
| n/a |
|---|
| Name | BDBM37273 |
|---|
| Synonyms: | 1-(2-phenylethyl)-3-[4-[(E)-3-phenylprop-2-enyl]-1-piperazinyl]pyrrolidine-2,5-dione | 1-(2-phenylethyl)-3-[4-[(E)-3-phenylprop-2-enyl]piperazin-1-yl]pyrrolidine-2,5-dione | 3-[4-[(E)-cinnamyl]piperazino]-1-phenethyl-pyrrolidine-2,5-quinone | MLS000107086 | SMR000111458 | cid_5310863 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C25H29N3O2 |
|---|
| Mol. Mass. | 403.5167 |
|---|
| SMILES | O=C1CC(N2CCN(C\C=C\c3ccccc3)CC2)C(=O)N1CCc1ccccc1 |
|---|
| Structure | 
|
|---|
Search and Browse
